GSK Says More Vaccines in India Because of Intellectual Property

September 07, 2005
GSK logoAn interesting article in the Hindu Business Line looks at the growing use of vaccines in India. Here is what caught my eye:
The reason why global drug/vaccine companies are bringing more products to India is because of the open market and the product-patent regime effective from this year, he [Dr Sanjoy K. Datta, Medical Director with GSK Biologicals] says.


CGD blog posts reflect the views of the authors, drawing on prior research and experience in their areas of expertise. CGD is a nonpartisan, independent organization and does not take institutional positions.